Antiaging Quantum Living Inc (AAQL)

[molee]

Buy rating and a $10 price target.

Achillion Pharmaceuticals ( ACHN) shares were up 2.2%, to $4.20.

Ladenburg Thalmann on Thursday initiated coverage of New Haven, Conn.-based Achillion with a buy rating and a $10 price target.

"We see two very clear pathways for significant value creation for investors," wrote Ladenburg analyst Christopher James in a note. "The first is with the ACH-4471 program for multiple rare diseases driven by disorders of the complement system. The second path is through its HCV program, which is partnered with Janssen Pharmaceuticals."

https://www.thestreet.com/story/13976492/1/premarket-biotech-movers-cytokinetics-achillion-qiagen.html?puc=yahoo&cm_ven=YAHOO